Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin

Agency for Quality and Accreditation in Health Care and Social Welfare (AAZ), Croatia
Record ID 32018001160
English
Authors' objectives: The health technologies assessed include rtCGM systems and FGM systems as personal, stand­alone medical devices for patients with diabetes mellitus type 1 and type 2 (T1DM and T2DM), including adults, children, and patients with gestational DM treated with insulin, either through insulin pump therapy (CSII) or multiple daily insulin injections (MDII). Professional (retrospective) devices are not included in this assessment. The objective of this rapid assessment was to evaluate the relative effectiveness and safety of real-time continuous glucose monitoring (rtCGM) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin. We do not provide any recommendations; this is left to national/regional and local HTA processes, appraisal processes, and decision-making.
Details
Project Status: Completed
Year Published: 2018
Requestor: HTA agencies
English language abstract: An English language summary is available
Publication Type: Rapid Review
MeSH Terms
  • Blood Glucose Self-Monitoring
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus
  • Diabetes Mellitus, Type 2
  • Adult
  • Child
  • Adolescent
  • Pregnancy in Diabetics
Contact
Organisation Name: European Network for Health Technology Assessment
Contact Email: eunethta@zinl.nl
Copyright: CC-BY-NC: You may copy, distribute, display, perform, and modify and use the EUnetHTA work for any purpose other than commercially unless you get your permission first.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.